| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1424897A2 Compositions and methods for treatment of cancer |
| 06/09/2004 | EP0975364B1 Allergen formulation |
| 06/09/2004 | EP0934081B1 Antineoplastic conjugates of albumin |
| 06/09/2004 | EP0809510B1 Lymphotoxin-alpha/beta complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | EP0547164B1 Methods for the diagnosis and treatment of diabetes |
| 06/09/2004 | CN1503843A Vaccination against host cell-associated herpesviruses |
| 06/09/2004 | CN1503806A Pepties from the 16/6id antibody for treating SLE |
| 06/09/2004 | CN1503678A Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 06/09/2004 | CN1503677A Use of LP 82 to treat hematopoietic disorders |
| 06/09/2004 | CN1503664A Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 06/09/2004 | CN1503628A Use of cell penetrating peptides to generate antitumor immunity |
| 06/09/2004 | CN1502368A Application of recombinant adenovirus in treating cerebral ischemia, traumatic restoration and tissue adhesion |
| 06/09/2004 | CN1502367A Immunoprophyaxis nose drops and preparation process thereof |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152960C ICAM-4 materials and methods |
| 06/09/2004 | CN1152867C Quinazoline derivatives as medicaments |
| 06/09/2004 | CN1152715C Vaccine composition containing polyribosylribitol phosphate and method for making same |
| 06/08/2004 | US6747784 Compliant mechanism and method of forming same |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6747136 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
| 06/08/2004 | US6747126 Peptide inhibitors of HIV entry |
| 06/08/2004 | US6747036 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 06/08/2004 | US6746869 Electrospraying apparatus and method for coating particles |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746677 For preventing and controlling helminthiasis, infection by acarids and arthropod endo-and ectoparasites and bacterial and viral disease in warm-blooded animals |
| 06/08/2004 | US6746676 Chlamydia proteins and their uses |
| 06/08/2004 | US6746673 For prophylaxis and/or treatment of an autoimmune disease or rheumatoid arthritis |
| 06/08/2004 | US6746669 Method for down-regulating IL5 activity |
| 06/08/2004 | CA2100256C A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion,and the use of said agents for said purpose |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004046380A1 Psoriasis diagnostics and therapeutics |
| 06/03/2004 | WO2004046363A1 Induced humoral immune response using promoters specifically active in antigen presenting cells |
| 06/03/2004 | WO2004046349A2 Human methionine aminopeptidase type 3 |
| 06/03/2004 | WO2004046310A2 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 06/03/2004 | WO2004046193A1 Method of acquiring human monoclonal antibody inhibting cancer cell proliferation |
| 06/03/2004 | WO2004046168A2 Recombinant hiv-1 subclass d envelope glycoproteins |
| 06/03/2004 | WO2004045641A2 Antigen-complexes |
| 06/03/2004 | WO2004045640A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | WO2004045639A1 Live attenuated vaccine against porcine pleuropneumonia |
| 06/03/2004 | WO2004045561A2 Use of ferritin for immunomodulation |
| 06/03/2004 | WO2004045559A2 Method for the prevention of malaria |
| 06/03/2004 | WO2004045555A2 Immunogenic epitopes for fibroblast growth factor 5 (fgf-5) presented by hla-a3 and hla-a2 |
| 06/03/2004 | WO2004045551A2 Pharmaceutical composition |
| 06/03/2004 | WO2004045550A2 Immunization with porphyromonas gingivalis protects against heart disease |
| 06/03/2004 | WO2004045532A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/03/2004 | WO2004045529A2 West nile virus vaccine |
| 06/03/2004 | WO2004045520A2 Complement receptor 2 targeted complement modulators |
| 06/03/2004 | WO2004045516A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/03/2004 | WO2004045507A2 Anti-angiogenic uses of il-6 antagonists |
| 06/03/2004 | WO2004045499A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 06/03/2004 | WO2004045495A2 Interacting site for gp41 on gp120 of hiv-1 |
| 06/03/2004 | WO2004033723A3 Neurodegenerative disease-associated gene |
| 06/03/2004 | WO2004029093A3 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004024769A3 Ostertagia vaccine |
| 06/03/2004 | WO2004020451A9 Group b streptococcal phage lysin |
| 06/03/2004 | WO2004018519A3 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 06/03/2004 | WO2004016283A3 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 06/03/2004 | WO2004013306A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 06/03/2004 | WO2004009021A3 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/03/2004 | WO2004002415A9 Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
| 06/03/2004 | WO2003106974A3 Diagnosis and treatment of chemoresistant tumors |
| 06/03/2004 | WO2003100432A3 Method for identifying immunoreactive peptides |
| 06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | WO2003079025A3 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 06/03/2004 | WO2003057159A9 Psoriasin expression by breast epithelial cells |
| 06/03/2004 | WO2003051310A3 Methods of inhibiting fertility |
| 06/03/2004 | WO2003024481A3 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/03/2004 | WO2003006104A8 Lymphatic endothelial cells materials and methods |
| 06/03/2004 | WO2003000928A3 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 06/03/2004 | WO2002093998A3 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106864 Method of predicting stroke evolution utilising mri |
| 06/03/2004 | US20040106780 Preparing antibody isolated from blood for treatment of thrombocytopenia, tetanus, rubella and viral diseases |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106771 Natural antibodie active against hiv virus |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106551 Human papilloma virus immunoreactive peptides |
| 06/03/2004 | US20040106194 Genetically engineered gene transfer vector comprising mutiple viral serotype sequences and E4 region of preferential virus for use as transfer tool in gene therapy and vaccine preparation |
| 06/03/2004 | US20040106174 Designing immunogens |
| 06/03/2004 | US20040106143 Monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 06/03/2004 | US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders |
| 06/03/2004 | US20040106128 Designing therapeutic immunoglobulins which act on polymerases to prevent and treat cell proliferative disorders; immunotherapy |
| 06/03/2004 | US20040106105 Vaccine |
| 06/03/2004 | US20040106100 Dna vaccines encoding hiv accessory proteins |
| 06/03/2004 | US20040105872 which contains a cytosine, guanine dinucleotide sequence and stimulates (for example, has a mitogenic effect) vertebrate immune cells |
| 06/03/2004 | US20040105871 Pox viral vector plasmid construct comprising a vaccine insert that encodes at least two antigens; DNA-based vaccine can be tailored for the type of immune response that will be mobilized |
| 06/03/2004 | US20040105868 HCV epitopes vaccines for immunization for Hepatitis C polypeptides for CD antigens |
| 06/03/2004 | US20040105866 Pneumococcal and meningococcal vaccines formulated with interleukin-12 |
| 06/03/2004 | US20040105865 Treatment and diagnosis of prostate cancer |
| 06/03/2004 | US20040105864 Food supplement |
| 06/03/2004 | US20040105863 Method to search for male antifertility drugs based on PHGPx activity determination |
| 06/03/2004 | US20040105862 Human TIMP-1 antibodies |
| 06/03/2004 | US20040105858 Controlling immune response for diagnosis of infertility, with immune response and spontaneous abortion using thalidomide |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |